HIKAL vs VIYASH: Stock Comparison

Hikal Limited vs Viyash Scientific Ltd

Live data: 22 July 2026, 3:05 PM IST • Source: NSE and company filings

Viyash Scientific Ltd is the larger company by market capitalisation. Hikal Limited shows a lower P/E, a higher dividend yield and faster revenue growth, while Viyash Scientific Ltd shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Hikal Limited and Viyash Scientific Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, HIKAL is more favourable on 5 of 13 scored metrics and VIYASH on 8These counts are context-free and are not an overall rating.

Key Differences

Market Cap
VIYASH is the larger company
₹11,242 Cr vs ₹2,637 Cr
P/E Ratio
HIKAL has a lower P/E
-56.64x vs 65.27x
P/B Ratio
HIKAL has a lower P/B
2.31x vs 3.98x
EPS
VIYASH has higher earnings per share
₹4.06 vs ₹-3.95
Dividend Yield
HIKAL has a higher dividend yield
0.44% vs 0%
Revenue Growth (TTM YoY)
HIKAL has faster revenue growth
37.3% vs 0%
EPS Growth (TTM YoY)
HIKAL has faster EPS growth
68.3% vs 0%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
129% vs -5.97%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricHIKALVIYASH
SectorHealthcare
IndustryPharmaceuticals

Price

MetricHIKALVIYASH
Live Price₹213.42₹257
Day Change-5.04%-3.07%
Volume3.53 L11.16 L
52-Week High₹343.85₹298
52-Week Low₹146.25₹178.13
Distance from 52W High-37.93%-13.76%

Valuation

MetricHIKALVIYASH
Market Cap₹2,637 Cr₹11,242 Cr
P/E Ratio-56.64x65.27x
P/B Ratio2.31x3.98x
EPS₹-3.95₹4.06
Book Value₹97.4₹66.6
Dividend Yield0.44%0%

Growth

MetricHIKALVIYASH
Revenue Growth (TTM YoY)37.3%0%
EPS Growth (TTM YoY)68.3%0%
Qtr Sales Growth-5.97%129%
Qtr Profit Growth22.5%455%

Profitability & Leverage

MetricHIKALVIYASH
ROE2.95%11%
ROCE3.52%19%
Net Margin-2.88%6.57%
Operating Margin12.9%19.1%
Debt to Equity0.57x0.17x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricHIKALVIYASH
Promoter Holding68.85%0%
FII Holding1.43% 0.87 pp2.94% 0.22 pp
DII Holding7.2% 0.15 pp7.99% 0.63 pp
Public Holding22.52% 0.73 pp27.67% 0.3 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Hikal Limited and Viyash Scientific Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.